References
- Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Public Law no. 108-173, 117 Stat 206 2003. [cited 2018 Jun]. Available from: https://www.gpo.gov/fdsys/pkg/PLAW-108publ173/pdf/PLAW-108publ173.pdf
- Centers for Medicare and Medicaid Services. National coverage determinations with data collection as a condition of coverage: coverage with evidence development; 2006 [cited 2016 Oct]. Available from: https://www.cms.gov/Medicare/Coverage/DeterminationProcess/Downloads/ced.pdf
- Academy of Managed Care Pharmacy. AMCP format for formulary submissions, version 4.0; 2016 [cited 2018 Jun]. Available from: http://www.amcp.org/FormatV4/
- Garrison LP Jr., Neumann PJ, Erickson P, et al. Using real-world data for coverage and payment decisions: the ISPOR real-world data task force report. Value Health. 2007;10(5):326–335.
- Li CM, Risebrough NA, Hux M. Coverage with evidence development activities around the world: an environment scan. Value Health. 2014;17(7):A449.
- Ovid Medline®. [cited 2018 Jun]. Available from: http://www.ovid.com/site/catalog/databases/index.jsp.
- Hyder AA, Corluka A, Winch PJ, et al. National policy-makers speak out: are researchers giving them what they need? Health Policy Plan. 2011;26(1):73–82.
- United Arab Emirates. Vision 2021. [cited 2018 Jun]. Available from: https://www.vision2021.ae/en.
- Kingdom of Saudi Arabia. Vision 2030. [cited 2018 Jun]. Available from: http://vision2030.gov.sa/en
- Verniers I, Stremersch S, Croux C. The global entry of new pharmaceuticals: a joint investigation of launch window and price. Int J Res Marketing. 2011;28(4):295–308.
- The Saudi Food and Drug Authority SFDA. [cited 2018 Jun]. Available from: https://www.sfda.gov.sa/En/Pages/default.aspx
- Egyptian Drug Authority. [cited 2018 Jun]. Available from: http://www.eda.mohp.gov.eg/
- Jordan Food and Drug Administration JFDA. [cited 2018 Jun]. Available from: http://jfda.jo/Default.aspx
- Ministry of Health and Protection, MOHP. [cited 2018 Jun]. Available from: http://www.mohap.gov.ae/en/Pages/default.aspx
- El-Jardali F, Bou Karroum L, Bawab L, et al. Health reporting in print media in Lebanon: evidence, quality and role in informing policymaking. PloS one. 2015;10(8):e0136435.
- El-Jardali F, Lavis JN, Ataya N, et al. Use of health systems evidence by policymakers in eastern Mediterranean countries: views, practices, and contextual influences. BMC Health Serv Res. 2012;12:200.
- El-Jardali F, Lavis JN, Ataya N, et al. Use of health systems and policy research evidence in the health policymaking in eastern Mediterranean countries: views and practices of researchers. Implement Sci. 2012;7:2.
- El-Jardali F, Ataya N, Jamal D, et al. A multi-faceted approach to promote knowledge translation platforms in eastern Mediterranean countries: climate for evidence-informed policy. Health Res Policy Syst. 2012;10:15.
- Brugger U, Ruckstuhl A, Horisberger B, et al. Development of coverage with evidence development for medical technologies in Switzerland from 1996 to 2012. Int J Technol Assess Health Care. 2014;30(3):253–259.
- Rahim HF, Sibai A, Khader Y, et al. Non-communicable diseases in the Arab world. Lancet. 2014;383(9914):356–367.
- The Lancet O. Addressing the burden of cancer in the Gulf. Lancet Oncol. 2014;15(13):1407.
- Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence - What is it and what can it tell us? N Engl J Med. 2016;375(23):2293–2297.
- Richard E, Gliklich NAD. Registries for evaluating patient outcomes, a user guide. 2nd ed. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Apr.
- Macintyre S. Evidence in the development of health policy. Public Health. 2012;126(3):217–219.